developing safe and effective agents for the treatment of cll
Published 6 years ago • 33 plays • Length 1:12Download video MP4
Download video MP3
Similar videos
-
3:07
developing guidelines for the management of infections following treatment with bispecifics
-
0:51
key unmet needs in the treatment of immune-mediated ttp
-
0:47
novel agents being explored for the treatment of immune-mediated ttp
-
1:44
the impact of acalabrutinib treatment by line of therapy in patients with cll
-
0:59
developing lsc-targeting agents in aml: progress and current therapeutic capacity
-
0:45
key trials in cll and designing a concept for treatment
-
56:47
laboratory quality control - documentation (day 1 | session 2)
-
3:14
who: lqsi series - implementing a laboratory quality management system
-
1:02:10
what is cll? - diagnosis and treatment
-
3:45
the treatment and management of cll across the globe
-
1:00
the role of non-covalent btk inhibitors in the treatment of non-hodgkin lymphoma
-
1:12
insights into the optimal management of cll: the importance of patient characteristics
-
1:25
the management of cll in italy
-
1:13
second-line treatment strategies for patients with relapsed dlbcl
-
1:28
the future of cll treatment
-
0:53
the future of cll treatment
-
1:33
key factors affecting treatment decision making in cll
-
3:29
how the management of cll is evolving
-
1:32
novel agent combinations: the future of cll
-
1:29
the importance of treatment sequencing in cll
-
2:36
novel non-immunological agents currently under investigation for cll
-
1:19
cll treatment: a look into the future